Newer Diabetes Drugs Cost More, But May Not Work Better, University of Michigan, Mayo Clinic And North Carolina State University Study

Published: Feb 28, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Two newer classes of drugs to treat adult-onset diabetes may be no more effective than the old standby, yet they cost significantly more over the course of a patient’s disease. That’s according to a National Science Foundation-funded study by researchers at the University of Michigan, Mayo Clinic and North Carolina State University.

Hey, check out all the research scientist jobs. Post your resume today!

Back to news